pfizer glp 1 drug Danuglipron: Pfizer's GLP-1 receptor agonist weight loss pill GLP-1 Agonists: A Comprehensive Overview
Description
In 2020, it was estimated that nearly 462 million people worldwide suffer from the disorder
Trends Neurosci
C.ChiuW
Longo DL, ed
After the initial Phase III studies showed the GLP-1/GIP agonists effectively lowered hemoglobin A1c levels, several influential randomized trials were published investigating their effects on cardiovascular outcomes in diabetic patients
